Satrin A, Piga M, Gatto M, Fuentes-Silva Y, Puerta JAG, Padjen I, Pons-Estel G, Ugarte-Gil MF, Toro-GutiÉrrez CE, Legge A, Duarte-Garcia A, Chasset F, Parodis I, Baumgaertner K, Chiche L, Monticielo OA, Oyoo O, Faria R, Izuka S, Silva-Ribeiro S, Togizbayev G, Opris-Belinski D, El Kibbi L, Aggarwal A, Maheswaranathan M et al. (2026)
International development and validation of a multilingual bank of items for the self-assessment of essential knowledge by systemic lupus erythematosus patients: the SLE Knowledge Assessment score (SLAKE)
Rheumatology (Oxford), 65 (2)
DOI 10.1093/rheumatology/keaf649, PubMed 41386268

Berger SG, Berntsen KS, Risum K, Marstein HS, Sjaastad I, Stokke MK, Sanner H (2025)
Predictors of persistent active disease and the longitudinal development of organ damage, patient-reported outcomes and autoantibodies in long-term juvenile dermatomyositis
RMD Open, 11 (2)
DOI 10.1136/rmdopen-2025-005598, PubMed 40480648

Bolla E, Semb AG, Petri M, Sfikakis PP, Artim-Esen B, Hernandez-Molina G, Hachulla E, Direskeneli H, Karpouzas GA, Zucchi D, Goyal M, Costedoat-Chalumeau N, Tincani A, Yazici A, Lerang K, Troldborg A, Ajeganova S, Popkova TV, Svenungsson E, Pantazis N, Tektonidou MG, SURF-SLE and APS collaborators (2025)
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries
Lancet Rheumatol, 8 (3), e192-e203
DOI 10.1016/S2665-9913(25)00257-7, PubMed 41274305